Skip to main content
main-content

Tipp

Weitere Artikel dieser Ausgabe durch Wischen aufrufen

Erschienen in: Wiener klinische Wochenschrift 11-12/2014

01.06.2014 | original article

Quality of care of rural rheumatoid arthritis patients in Austria

verfasst von: MD Dr. Rudolf Puchner, MD, PhD Hans Peter Brezinschek, MD, PhD Manfred Herold, MD Thomas Nothnagl, MD Andrea Studnicka-Benke, DI Josef Fritz, MD, PhD Burkhard F. Leeb

Erschienen in: Wiener klinische Wochenschrift | Ausgabe 11-12/2014

Einloggen, um Zugang zu erhalten
share
TEILEN

Summary

Objectives

To determine how fast rheumatoid arthritis (RA) was diagnosed in a group of patients in a rural area and whether medical care and patient satisfaction were adequate in a predominantly non-urban settlement.

Methods

When visiting their rheumatologist, patients with RA were asked to complete a questionnaire at home after the consultation and then return it to an independent opinion research centre, where the data were collected and analysed. The form comprised various areas, namely demography, aspects of the diagnosis, medical care, therapeutic measures and the illness in a personal context.

Results

Of 150 patients, 127 answered the questionnaire. A total of 63 % of the patients lived in settlements of less than 5,000 inhabitants, and a further 18 % in settlements of more than 5,000–50,000 inhabitants. The rheumatologist attended could be reached within 1 h for 90 % of the patients.
In slightly fewer than 30 % of the respondents, the diagnosis of RA was made within 3 months, and in 44%, within 6 months. In 75 %, the diagnosis was made by a rheumatologist. After experiencing the first symptoms, 80 % of the respondents contacted their general practitioner. A high degree of satisfaction appears to originate from the information supplied by the rheumatologist attended. Most patients believed they were involved in decision making regarding their therapy.

Conclusion

The majority of the respondents came from rural areas. RA was diagnosed within 6 months for almost half of the patients questioned. Most patients believed they were well informed and involved in therapeutic decision making.
Anhänge
Nur mit Berechtigung zugänglich
Literatur
1.
Zurück zum Zitat Basu N, Steven M. A comparison of rural and urban rheumatoid arthritis populations. Scott Med J. 2009;54(1):7–9. PubMedCrossRef Basu N, Steven M. A comparison of rural and urban rheumatoid arthritis populations. Scott Med J. 2009;54(1):7–9. PubMedCrossRef
2.
Zurück zum Zitat Bejarano V, Quinn M, Conaghan PG, et al.; Yorkshire Early Arthritis Register Consortium. Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis. Arthritis Rheum. 2008;59:1467–74. PubMedCrossRef Bejarano V, Quinn M, Conaghan PG, et al.; Yorkshire Early Arthritis Register Consortium. Effect of the early use of the anti-tumor necrosis factor adalimumab on the prevention of job loss in patients with early rheumatoid arthritis. Arthritis Rheum. 2008;59:1467–74. PubMedCrossRef
3.
Zurück zum Zitat Buitinga L, Braakman-Jansen LM, van de Laar MA. Future expectations and worst-case future scenarios of patients with rheumatoid arthritis: a focus group study. Musculoskeletal Care. 2012;10(4):240–7. PubMedCrossRef Buitinga L, Braakman-Jansen LM, van de Laar MA. Future expectations and worst-case future scenarios of patients with rheumatoid arthritis: a focus group study. Musculoskeletal Care. 2012;10(4):240–7. PubMedCrossRef
4.
Zurück zum Zitat Bykerk V, Emery P. Delay in receiving rheumatology care leads to long term harm. Arthritis Rheum. 2010;62:3519–21. PubMedCrossRef Bykerk V, Emery P. Delay in receiving rheumatology care leads to long term harm. Arthritis Rheum. 2010;62:3519–21. PubMedCrossRef
5.
Zurück zum Zitat Carr A, Hewlett S, Hughes R, Mitchell H, Ryan S, Carr M, Kirwan J. Rheumatology outcomes: the patient's perspective. J Rheumatol. 2003;30:880–3. PubMed Carr A, Hewlett S, Hughes R, Mitchell H, Ryan S, Carr M, Kirwan J. Rheumatology outcomes: the patient's perspective. J Rheumatol. 2003;30:880–3. PubMed
6.
Zurück zum Zitat Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum. 2005;52:3381–90. PubMedCrossRef Goekoop-Ruiterman YP, de Vries-Bouwstra JK, Allaart CF, et al. Clinical and radiographic outcomes of four different treatment strategies in patients with early rheumatoid arthritis (the BeSt study): a randomized, controlled trial. Arthritis Rheum. 2005;52:3381–90. PubMedCrossRef
7.
Zurück zum Zitat Gromnica-Ihle E. Rink M. Treat to target from the patient perspective. Z Rheumatol. 2011;70:678–84. Gromnica-Ihle E. Rink M. Treat to target from the patient perspective. Z Rheumatol. 2011;70:678–84.
8.
Zurück zum Zitat Hill J, Bird H, Johnson S. Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis. 2001;60:869–75. PubMedCentralPubMed Hill J, Bird H, Johnson S. Effect of patient education on adherence to drug treatment for rheumatoid arthritis: a randomised controlled trial. Ann Rheum Dis. 2001;60:869–75. PubMedCentralPubMed
9.
Zurück zum Zitat Jaccobi C, Boshuizen H, Rupp I, et al. Quality of rheumatoid arthritis care: the patient's perspective. Int J Qual Health Care. 2004;16:73–81. CrossRef Jaccobi C, Boshuizen H, Rupp I, et al. Quality of rheumatoid arthritis care: the patient's perspective. Int J Qual Health Care. 2004;16:73–81. CrossRef
10.
Zurück zum Zitat Kalden JR, Müller-Ladner U, Schmiedt RE. Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis. Z Rheumatol. 2011;70:641–50. PubMedCrossRef Kalden JR, Müller-Ladner U, Schmiedt RE. Strategies for improved healthcare of people with the endemic disease rheumatism exemplified by rheumatoid arthritis. Z Rheumatol. 2011;70:641–50. PubMedCrossRef
11.
Zurück zum Zitat Kjeken I, Dagfinrud H, Mowinckel P, et al. Rheumatology care: involvement in medical decisions, received information, satisfaction with care, and unmet health care needs in patients with rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum. 2006;55:394–401. PubMedCrossRef Kjeken I, Dagfinrud H, Mowinckel P, et al. Rheumatology care: involvement in medical decisions, received information, satisfaction with care, and unmet health care needs in patients with rheumatoid arthritis and ankylosing spondylitis. Arthritis Rheum. 2006;55:394–401. PubMedCrossRef
12.
Zurück zum Zitat Krüger K, Karberg K. Treat-to-target from the perspective of office-based rheumatology. Z Rheumatol. 2011;70:664–9. PubMedCrossRef Krüger K, Karberg K. Treat-to-target from the perspective of office-based rheumatology. Z Rheumatol. 2011;70:664–9. PubMedCrossRef
13.
Zurück zum Zitat Machold KP, Stamm TA, Nell VPK, et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiograph progression over the first years of disease. Rheumatology (Oxford). 2007;46:342–9. CrossRef Machold KP, Stamm TA, Nell VPK, et al. Very recent onset rheumatoid arthritis: clinical and serological patient characteristics associated with radiograph progression over the first years of disease. Rheumatology (Oxford). 2007;46:342–9. CrossRef
14.
Zurück zum Zitat Mottonen T, Hannonen P, Korpela M, et al.; FIN-RACo Trial Group. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum. 2002;46:894–8. PubMedCrossRef Mottonen T, Hannonen P, Korpela M, et al.; FIN-RACo Trial Group. Delay to institution of therapy and induction of remission using single-drug or combination-disease-modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum. 2002;46:894–8. PubMedCrossRef
15.
Zurück zum Zitat Nell VP, Machold KP, Eberl G, et al. Benefit of very early referral and very early therapy with disease-modifying, anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford). 2004;43:906–14. CrossRef Nell VP, Machold KP, Eberl G, et al. Benefit of very early referral and very early therapy with disease-modifying, anti-rheumatic drugs in patients with early rheumatoid arthritis. Rheumatology (Oxford). 2004;43:906–14. CrossRef
16.
Zurück zum Zitat Puchner R. Job satisfaction and future prospects among Austrian rheumatologists. Z Rheumatol. 2010;69:818–29. PubMedCrossRef Puchner R. Job satisfaction and future prospects among Austrian rheumatologists. Z Rheumatol. 2010;69:818–29. PubMedCrossRef
17.
Zurück zum Zitat Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes. Arthritis Care Res (Hoboken). 2010;62:647–56. CrossRef Sanderson T, Morris M, Calnan M, Richards P, Hewlett S. Patient perspective of measuring treatment efficacy: the rheumatoid arthritis patient priorities for pharmacologic interventions outcomes. Arthritis Care Res (Hoboken). 2010;62:647–56. CrossRef
19.
Zurück zum Zitat Schipper LG, van Hulst LT, Grol R, et al. Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome. Rheumatology. 2010;49:2154–64. PubMedCrossRef Schipper LG, van Hulst LT, Grol R, et al. Meta-analysis of tight control strategies in rheumatoid arthritis: protocolized treatment has additional value with respect to the clinical outcome. Rheumatology. 2010;49:2154–64. PubMedCrossRef
20.
Zurück zum Zitat Smolen JS, Aletaha D, Bijlsma JW, et al.; T2T Expert Committee. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631–7. PubMedCentralPubMedCrossRef Smolen JS, Aletaha D, Bijlsma JW, et al.; T2T Expert Committee. Treating rheumatoid arthritis to target: recommendations of an international task force. Ann Rheum Dis. 2010;69:631–7. PubMedCentralPubMedCrossRef
21.
Zurück zum Zitat Smolen JS, Landewe R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010;69:964–75. PubMedCentralPubMedCrossRef Smolen JS, Landewe R, Breedveld FC, et al. EULAR recommendations for the management of rheumatoid arthritis with synthetic and biological disease-modifying antirheumatic drugs. Ann Rheum Dis. 2010;69:964–75. PubMedCentralPubMedCrossRef
22.
Zurück zum Zitat Van der Linden MP, le Cessie S, Raza K, et al. Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum. 2010;62:3537–46. Van der Linden MP, le Cessie S, Raza K, et al. Long-term impact of delay in assessment of patients with early arthritis. Arthritis Rheum. 2010;62:3537–46.
23.
Zurück zum Zitat Van Nies JA, De Jong Z, Van der Helm-van Mil AH, et al. Improved treatment strategies reduce the increased mortality risk in early RA patients. Rheumatology. 2010;49:2210–6. PubMedCrossRef Van Nies JA, De Jong Z, Van der Helm-van Mil AH, et al. Improved treatment strategies reduce the increased mortality risk in early RA patients. Rheumatology. 2010;49:2210–6. PubMedCrossRef
24.
Zurück zum Zitat Verstappen SM, Bijsma JW, Verklej H, et al. Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Rheum. 2004;51:488–97. PubMedCrossRef Verstappen SM, Bijsma JW, Verklej H, et al. Overview of work disability in rheumatoid arthritis patients as observed in cross-sectional and longitudinal surveys. Arthritis Rheum. 2004;51:488–97. PubMedCrossRef
25.
Zurück zum Zitat Verstappen SM, Watson KT, Lunt M, et al. Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology. 2010;49:1570–7. PubMedCentralPubMedCrossRef Verstappen SM, Watson KT, Lunt M, et al. Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register. Rheumatology. 2010;49:1570–7. PubMedCentralPubMedCrossRef
26.
Zurück zum Zitat Westhoff G, Edelmann E, Kekow J, Zink A. Diagnostic spectrum, treatment indication and symptom duration in initial referrals to the rheumatologist. Z Rheumatol. 2010;69:910–8. PubMedCrossRef Westhoff G, Edelmann E, Kekow J, Zink A. Diagnostic spectrum, treatment indication and symptom duration in initial referrals to the rheumatologist. Z Rheumatol. 2010;69:910–8. PubMedCrossRef
27.
Zurück zum Zitat Zink A, Huscher D, Schneider M. How closely does rheumatology treatment follow the guidelines? Ambition and reality. Z Rheumatol. 2010;9:318–26. CrossRef Zink A, Huscher D, Schneider M. How closely does rheumatology treatment follow the guidelines? Ambition and reality. Z Rheumatol. 2010;9:318–26. CrossRef
Metadaten
Titel
Quality of care of rural rheumatoid arthritis patients in Austria
verfasst von
MD Dr. Rudolf Puchner
MD, PhD Hans Peter Brezinschek
MD, PhD Manfred Herold
MD Thomas Nothnagl
MD Andrea Studnicka-Benke
DI Josef Fritz
MD, PhD Burkhard F. Leeb
Publikationsdatum
01.06.2014
Verlag
Springer Vienna
Erschienen in
Wiener klinische Wochenschrift / Ausgabe 11-12/2014
Print ISSN: 0043-5325
Elektronische ISSN: 1613-7671
DOI
https://doi.org/10.1007/s00508-014-0540-6